Nvidia AI Server Prices Set to Rise as Memory Costs Surge 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
SK Hynix Shares Surge on Record $28.6 Billion Buyback 
Alibaba Shares Fall as AI Spending Hits Profit 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead 
Welspun Corp Shares Hit Record High on $1.8 Billion U.S. Order 
Standard Chartered Expands Hedge Fund Access for Wealth Clients 
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3 
Hyundai Motor Union Launches First Full Strike in Decade Over Wages, AI Job Risks 
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised 
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion 
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks 
Apple Cuts Over 200 Siri, Vision Pro Jobs in AI Shift 
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut 
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth 
REPAY Stock Rises After Visa Platform Connect Collaboration 
Add as a preferred source on Google
ST. LOUIS, May 04, 2018 -- Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2018 first quarter ended March 31, 2018 on Monday, May 14, 2018 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10:00 a.m. Eastern Time that day to discuss the Company’s results and corporate developments.
| What: | Stereotaxis first quarter 2018 financial results conference call | |||||||
| When: | Monday, May 14th at 10:00 a.m. Eastern Time (7:00 a.m. PT) | |||||||
| Dial In Number: | To access the live call, dial 800-289-0438 (US and Canada) or 323-794-2423 (International) and give the participant pass code 7909480. | |||||||
| Webcast: | To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at www.stereotaxis.com. | |||||||
| Call Replay: | A phone replay of the call will be available for one week beginning approximately two hours following the end of the call through Monday, May 21, 2018. To access the replay dial-in information, please click here. | |||||||
About Stereotaxis
Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Over 100 issued patents support the Stereotaxis platform. The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere. For more information, please visit www.stereotaxis.com.
Company Contacts:
David L. Fischel
Chairman and Chief Executive Officer
Martin C. Stammer
Chief Financial Officer
314-678-6100
[email protected]
